Mitochondrial dysfunction in Parkinson's disease

Cited by (690)

Items 301–400 of 690

1. Mitochondrial remodeling in human skin fibroblasts from sporadic male Parkinson's disease patients uncovers metabolic and mitochondrial bioenergetic defects
   Cláudia M. Deus, Susana P. Pereira, Teresa Cunha‐Oliveira, Francisco Baptista Pereira, Nuno Raimundo, Paulo Jorge Oliveira · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
2. ATP-sensitive Potassium Channel Subunits in Neuroinflammation: Novel Drug Targets in Neurodegenerative Disorders
   Fatima Maqoud, Rosa Scala, Malvina Hoxha, Bruno Zappacosta, Domenico Tricarico · 2021 · CNS & Neurological Disorders - Drug Targets
3. Hypertonia-linked protein Trak1 functions with mitofusins to promote mitochondrial tethering and fusion
   Crystal A. Lee, Lih‐Shen Chin, Lian Li · 2017 · Protein & Cell
4. Morphological analysis of mitochondria for evaluating the toxicity of α-synuclein in transgenic mice and isolated preparations by atomic force microscopy
   Ge Gao, Zhipeng Wang, Lingling Lu, Chunli Duan, Xiaomin Wang, Hui Yang · 2017 · Biomedicine & Pharmacotherapy
5. Chronic Dichlorvos Exposure: Microglial Activation, Proinflammatory Cytokines and Damage to Nigrostriatal Dopaminergic System
   Balachandran Krishnamma Binukumar, Amanjit Bal, Kiran Dip Gill · 2011 · NeuroMolecular Medicine
6. Protective effects of apigenin against 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in PC12 cells
   Weihai Liu, Songzhi Kong, Qingfeng Xie, Jiyan Su, Wenjie Li, Huizhen Guo, Shanshan Li, Xue-Xuan Feng, Ziren Su, YANG XU et al. · 2014 · International Journal of Molecular Medicine
7. In Vivo Quantification Reveals Extensive Natural Variation in Mitochondrial Form and Function in Caenorhabditis briggsae
   Kiley A. Hicks, Dana K. Howe, Aubrey Leung, Dee R. Denver, Suzanne Estes · 2012 · PLoS ONE
8. Evaluation of Carnosine Intervention in the Thy1-aSyn Mouse Model of Parkinson's Disease
   Mei-Ling Bermúdez, Kim B. Seroogy, Mary Beth Genter · 2019 · Neuroscience
9. Sesaminol prevents Parkinson's disease by activating the Nrf2-ARE signaling pathway
   Haruka Kaji, Isao Matsui‐Yuasa, Kayo Matsumoto, Ayano Omura, Kunio Kiyomoto, Akiko Kojima‐Yuasa · 2020 · Heliyon
10. Role of PITRM1 in Mitochondrial Dysfunction and Neurodegeneration
    Dario Brunetti, Alessia Catania, Carlo Fiore Viscomi, Michela Deleidi, Laurence Albert Bindoff, Daniele Ghezzi, Massimo Zeviani · 2021 · Biomedicines
11. Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice
    Yolanda Paes-Colli, Andrey F. L. Aguiar, Alinny Rosendo Isaac, Bruna Klippel Ferreira, Raquel Maria Pereira Campos, Priscila Martins Pinheiro Trindade, Ricardo Augusto de Melo Reis, Luzia da Silva Sampaio · 2022 · Frontiers in Cellular Neuroscience
12. New Insights into the Role of Cysteine Cathepsins in Neuroinflammation
    Anja Hafner Pišlar, Lara Bolčina, Janko Kos · 2021 · Biomolecules
13. Dieckol, an edible seaweed polyphenol, retards rotenone-induced neurotoxicity and α-synuclein aggregation in human dopaminergic neuronal cells
    Seon‐Heui Cha, Soo‐Jin Heo, You‐Jin Jeon, Sang Myun Park · 2016 · RSC Advances
14. Thymoquinone alleviates arsenic induced hippocampal toxicity and mitochondrial dysfunction by modulating mPTP in Wistar rats
    Fakiha Firdaus, Mohd Faraz Zafeer, Mohammad Waseem, Rizwan Ullah, Masood Ahmad, Mohammad Afzal · 2018 · Biomedicine & Pharmacotherapy
15. S-Denitrosylation: A Crosstalk between Glutathione and Redoxin Systems
    Surupa Chakraborty, Esha Sircar, Camelia Bhattacharyya, Ankita Choudhuri, Akansha Mishra, Sreejita Dutta, Sneha Bhatta, Kumar Sachin, Rajib Sengupta · 2022 · Antioxidants
16. LC/MS characterization of rotenone induced cardiolipin oxidation in human lymphocytes: Implications for mitochondrial dysfunction associated with Parkinson's disease
    Yulia Y. Tyurina, Daniel Winnica, Valentyna I. Kapralova, Alexandr A. Kapralov, Vladimir A. Tyurin, Valerian E. Kagan · 2013 · Molecular Nutrition & Food Research
17. Role of the VPS35 D620N mutation in Parkinson's disease
    Megha Mohan, George D. Mellick · 2016 · Parkinsonism & Related Disorders
18. Impaired Mitochondrial Fatty Acid Synthesis Leads to Neurodegeneration in Mice
    R. Nair, Henna Koivisto, Kimmo T. Jokivarsi, Ilkka Miinalainen, Kaija J. Autio, Aki Manninen, Pekka Poutiainen, Heikki Tanila, J. Kalervo Hiltunen, Alexander J. Kastaniotis · 2018 · Journal of Neuroscience
19. Caenorhabditis elegans neuron degeneration and mitochondrial suppression caused by selected environmental chemicals.
    Shaoyu Zhou, Zemin Wang, James E. Klaunig · 2013 · Europe PMC (PubMed Central)
20. A Transcriptome Analysis of mRNAs and Long Non-Coding RNAs in Patients with Parkinson’s Disease
    Michele Salemi, Giuseppe Lanza, Maria Paola Mogavero, F. Cosentino, Eugenia Borgione, Roberta Iorio, Giovanna Maria Ventola, Giovanna Marchese, Maria Grazia Salluzzo, Maria Ravo et al. · 2022 · International Journal of Molecular Sciences
21. Upregulation of 3-MST Relates to Neuronal Autophagy After Traumatic Brain Injury in Mice
    Mingyang Zhang, Haiyan Shan, Pan Chang, Lu Ma, Yang Chu, Xi Zhong SHEN, Qiong Wu, Zufeng Wang, Chengliang Luo, Tao Wang et al. · 2016 · Cellular and Molecular Neurobiology
22. Neuroprotective effects of 2,4-dinitrophenol in an acute model of Parkinson’s disease
    Yujeong Lee, Gwangbeom Heo, Kyung Moon Lee, Ah Hyun Kim, Ki Wung Chung, Eunok Im, Hae Young Chung, Jaewon Lee · 2017 · Brain Research
23. Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein
    Xu‐zhao Li, Shuai‐nan Zhang, Kexin Wang, Hongyu Liu, Zhiming Yang, Shumin Liu, Fang Lü · 2013 · Phytomedicine
24. The Effect of Aging on Mitochondrial Complex I and the Extent of Oxidative Stress in the Rat Brain Cortex
    Zuzana Tatarková, Mária Kovalská, Veronika Timková, Peter Račay, Ján Lehotský, Peter Kaplán · 2016 · Neurochemical Research
25. Neurodegeneration: Impact of S-nitrosylated Parkin, DJ-1 and PINK1 on the pathogenesis of Parkinson's disease
    Esha Sircar, Sristi Rai Raj, Mark A. Wilson, Michael G. Schlossmacher, Rajib Sengupta · 2021 · Archives of Biochemistry and Biophysics
26. Central Parkin: The evolving role of Parkin in the heart
    Gerald W. Dorn · 2016 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
27. Discovery of 1-(3-(benzyloxy)pyridin-2-yl)-3-(2-(piperazin-1-yl)ethyl)urea: A new modulator for amyloid beta-induced mitochondrial dysfunction
    Ahmed Elkamhawy, Jung-eun Park, Ahmed H.E. Hassan, Hyunhwa Ra, Ae Nim Pae, Jiyoun Lee, Beoung-Geon Park, Bongjin Moon, Hyun‐Mee Park, Eun Joo Roh · 2016 · European Journal of Medicinal Chemistry
28. α-synuclein and Parkinson’s disease: a proteomic view
    Mauro Fasano, Leonardo Lopiano · 2008 · Expert Review of Proteomics
29. Comprehensive blood metabolomics profiling of Parkinson’s disease reveals coordinated alterations in xanthine metabolism
    Elisa Gómez de Lope, Rebecca Ting Jiin Loo, Armin Rauschenberger, Muhammad Ali, Lukas Pavelka, Tainá M. Marques, Clarissa P. C. Gomes, Rejko Krüger, Enrico Glaab, Geeta Acharya et al. · 2024 · npj Parkinson s Disease
30. Acute exposure to a Mn/Zn ethylene-bis-dithiocarbamate fungicide leads to mitochondrial dysfunction and increased reactive oxygen species production in Caenorhabditis elegans
    Callie E. Todt, Denise C. Bailey, Aireal S. Pressley, Sarah E. Orfield, Rachel D. Denney, Isaac B. Snapp, Rekek Negga, Andrew C. Bailey, Kara M. Montgomery, Wendy L. Traynor et al. · 2016 · NeuroToxicology
31. The impact of genetic research on our understanding of Parkinson’s disease
    Ian Martin, Valina Lynn Dawson, Ted M. Dawson · 2010 · Progress in brain research
32. Molecular Mechanisms of Parkinson's Disease
    Zeinab Rezaee, Mohammad Marandi, Hojjatallah Alaei, Fahimeh Esfarjani · 2019 · The Neuroscience Journal of Shefaye Khatam
33. Novel siRNA delivery strategy: a new "strand" in CNS translational medicine?
    Gherardini, Lisa, Bardi, Giuseppe, Gennaro, Mariangela, Pizzorusso, Tommaso · 2014 · Cellular and Molecular Life Sciences
34. Crosstalk between DNA damage and cGAS-STING immune pathway drives neuroinflammation and dopaminergic neurodegeneration in Parkinson’s disease
    Sazzad Khan, David F. Delotterie, Jianfeng Xiao, Ramasamy Thangavel, Roderick T. Hori, James B. Koprich, Stephen E. Alway, Michael P. McDonald, Mohammad Moshahid Khan · 2025 · Brain Behavior and Immunity
35. Cathepsin L is involved in 6-hydroxydopamine induced apoptosis of SH-SY5Y neuroblastoma cells
    Bei Xiang, Xifeng Fei, Wenzhuo Zhuang, Yun Hua Fang, Zheng‐Hong Qin, Zhong‐Qin Liang · 2011 · Brain Research
36. Altered Ca2+ homeostasis in the skeletal muscle of DJ−1 null mice
    Alexander Shtifman, Nan Zhong, Jose Rafael Lopez, Jie Shen, Jin Xu · 2009 · Neurobiology of Aging
37. Caenorhabditis elegans chronically exposed to a Mn/Zn ethylene-bis-dithiocarbamate fungicide show mitochondrial Complex I inhibition and increased reactive oxygen species
    Denise C. Bailey, Callie E. Todt, Sarah E. Orfield, Rachel D. Denney, Isaac B. Snapp, Rekek Negga, Kara M. Montgomery, Andrew C. Bailey, Aireal S. Pressley, Wendy L. Traynor et al. · 2016 · NeuroToxicology
38. Using induced pluripotent stem cells for modeling Parkinson’s disease
    Minjing Ke, Cheong‐Meng Chong, Huanxing Su · 2019 · World Journal of Stem Cells
39. The oligosaccharide portion of ganglioside GM1 regulates mitochondrial function in neuroblastoma cells
    Maria Fazzari, Matteo Audano, Giulia Lunghi, Erika Di Biase, Nicoletta Loberto, Laura Mauri, Nico Mitro, Sandro Sonnino, Elena Chiricozzi · 2020 · Glycoconjugate Journal
40. Increase in endoplasmic reticulum-associated tissue transglutaminase and enzymatic activation in a cellular model of Parkinson's disease
    Robin Verhaar, Benjamin Drukarch, John G. J. M. Bol, Cornelis A.M. Jongenelen, René J.P. Musters, Micha M.M. Wilhelmus · 2011 · Neurobiology of Disease
41. Stem cell mitochondria during aging
    Jason Chua Min‐Wen, Elwin Tan Jun‐Hao, Ng Shyh‐Chang · 2016 · Seminars in Cell and Developmental Biology
42. Modulation of mitochondrial phenotypes by endurance exercise contributes to neuroprotection against a MPTP-induced animal model of PD
    Yongchul Jang, Insu Kwon, Wankeun Song, Ludmila Cosío-Lima, Scott M. Taylor, Youngil Lee · 2018 · Life Sciences
43. Lysosomal peptidases—intriguing roles in cancer progression and neurodegeneration
    Janko Kos, Ana Mitrović, Milica Perišić Nanut, Anja Hafner Pišlar · 2022 · FEBS Open Bio
44. Imaging the impact of genes on Parkinson's disease
    Joyce P. M. van der Vegt, Bart F.L. van Nuenen, Bastiaan R. Bloem, Christine Klein, Hartwig Roman Siebner · 2009 · Neuroscience
45. Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases
    Carlo Rodolfo, Fabiola Ciccosanti, Giuseppina Di Giacomo, Mauro Piacentini, Gian María Fimia · 2010 · Expert Review of Proteomics
46. Parkinson's syndrome and Parkinson's disease in mitochondrial disorders
    Josef Finsterer · 2011 · Movement Disorders
47. CRISPR-Cas9 Mediated Telomere Removal Leads to Mitochondrial Stress and Protein Aggregation
    Hyojung Kim, Sangwoo Ham, Minkyung Jo, Gum Hwa Lee, Yun‐Song Lee, Joo‐Ho Shin, Yunjong Lee · 2017 · International Journal of Molecular Sciences
48. Effect of in vitro storage duration on measured mechanical properties of brain tissue
    Wei Zhang, Li-fu Liu, Yue-jiao Xiong, Yi-fan Liu, Sheng‐Bo Yu, Chengwei Wu, Weihong Guo · 2018 · Scientific Reports
49. Outlook of PINK1/Parkin signaling in molecular etiology of Parkinson’s disease, with insights into Pink1 knockout models
    Zhangting Wang, See-Wing Chan, Hui Zhao, Kai-Kei Miu, Wai‐Yee Chan · 2023 · 动物学研究
50. The serine protease HtrA2/Omi cleaves Parkin and irreversibly inactivates its E3 ubiquitin ligase activity
    Hye Min Park, Goo-Young Kim, Min‐Kyung Nam, Geun-Hye Seong, Chul Han, Kwang Chul Chung, Seongman Kang, Hyangshuk Rhim · 2009 · Biochemical and Biophysical Research Communications
51. Therapeutic Potential of Citrus sinensis Peels Against Rotenone Induced Parkinsonism in Rats
    Manal Abdel Aziz Hamed, Asmaa F. Aboul Naser, Marwa Mahmoud Elbatanony, Amal Mohamed El-Feky, Azza Abdelmageed Matloub, Nagy Saba El-Rigal, Wagdy K. B. Khalil · 2020 · Current Bioactive Compounds
52. Plasma Metabolite Markers of Parkinson’s Disease and Atypical Parkinsonism
    Meerakhan Pathan, Junfang Wu, Hans‐Åke Lakso, Lars Forsgren, Anders Öhman · 2021 · Metabolites
53. Pale Body-Like Inclusion Formation and Neurodegeneration following Depletion of 26S Proteasomes in Mouse Brain Neurones are Independent of α-Synuclein
    Simon Paine, Glenn W. Anderson, Karen Bedford, Karen Lawler, R. John Mayer, James S Lowe, Lynn Bedford · 2013 · PLoS ONE
54. Subcellular ROS imaging methods: Relevance for the study of calcium signaling
    David M. Booth, Suresh K. Joseph, György Hajnóczky · 2016 · Cell Calcium
55. Up-regulation of HIF-1α is associated with neuroprotective effects of agmatine against rotenone-induced toxicity in differentiated SH-SY5Y cells
    N. Ferlazzo, M. Currò, Maria Laura Giunta, D. Longo, Valentina Rizzo, D. Caccamo, R. Ientile · 2019 · Amino Acids
56. Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Alzheimer Disease
    Roula Al‐Dahhak, Rita Khoury, Erum Qazi, George Thomas Grossberg · 2018 · Clinics in Geriatric Medicine
57. High-throughput screening and classification of chemicals and their effects on neuronal gene expression using RASL-seq
    Jeremy M. Simon, Smita R. Paranjape, Justin M. Wolter, Gabriela Salazar, Mark J. Zylka · 2019 · Scientific Reports
58. The relationship between parkin and protein aggregation in neurodegenerative diseases
    Preeti J. Khandelwal · 2010 · Frontiers in Psychiatry
59. Genetics of Parkinson’s Disease - A Clinical Perspective
    Sang‐Myung Cheon, Lilian Chan, Daniel Kam Yin Chan, Jae Woo Kim · 2012 · Journal of Movement Disorders
60. Redefining the roles of mitochondrial DNA-encoded subunits in respiratory Complex I assembly
    Rasika S. Vartak, Janice Deng, Hezhi Fang, Yidong Bai · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
61. Nitric oxide–cyclic GMP signaling pathway limits inflammatory degeneration of midbrain dopaminergic neurons: Cell type-specific regulation of heme oxygenase-1 expression
    Yuki Kurauchi, Akinori Hisatsune, Yoichiro Isohama, Hiroshi Katsuki · 2008 · Neuroscience
62. Towards diversity in genomics: The emergence of neurogenomics in Africa?
    Emmanuel Quansah, Nathaniel W. McGregor · 2017 · Genomics
63. Dietary Antioxidants and the Mitochondrial Quality Control: Their Potential Roles in Parkinson’s Disease Treatment
    Davin Lee, Min Gu Jo, Seung Yeon Kim, Chang Geon Chung, Sung Bae Lee · 2020 · Antioxidants
64. Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson’s disease?
    Sharon Hassin‐Baer, Oren S. Cohen, Eli Vakil, Noa Molshazki, Ben‐Ami Sela, Zeev Nitsan, Joab Chapman, David Tanné · 2010 · Journal of Neural Transmission
65. Ganoderma Lucidum polysaccharides protect against MPP(+) and rotenone-induced apoptosis in primary dopaminergic cell cultures through inhibiting oxidative stress.
    Shanshan Guo, Xiao-Lan Cui, Wolf‐Dieter Rausch · 2016 · Europe PMC (PubMed Central)
66. Post-Translational Oxidative Modifications of Mitochondrial Complex I (NADH: Ubiquinone Oxidoreductase): Implications for Pathogenesis and Therapeutics in Human Diseases
    M. M. Srinivas Bharath · 2017 · Journal of Alzheimer s Disease
67. Replacement of the C6ORF66 Assembly Factor (NDUFAF4) Restores Complex I Activity in Patient Cells
    Dana Marcus, Michal Lichtenstein, Ann Saada, Haya Lorberboum‐Galski · 2013 · Molecular Medicine
68. The Impact of CRISPR-Cas9 on Age-related Disorders: From Pathology to Therapy
    Allen Caobi, Rajib Kumar Dutta, Luis D. Garbinski, María Esteban-López, Yasemin Ceyhan, Mickensone Andre, Marko Manevski, Chet Raj Ojha, Jessica Lapierre, Sneham Tiwari et al. · 2020 · Aging and Disease
69. Neurotransmitter CART as a New Therapeutic Candidate for Parkinson’s Disease
    Peizhong Mao, Charles K. Meshul, Philippe Thuillier, Prashanth Reddy · 2013 · Pharmaceuticals
70. Intranasal carnosine attenuates transcriptomic alterations and improves mitochondrial function in the Thy1-aSyn mouse model of Parkinson's disease
    Mei-Ling Bermúdez, Matthew R. Skelton, Mary Beth Genter · 2018 · Molecular Genetics and Metabolism
71. Neuroprotective effects of Hibiscus Sabdariffa against hydrogen peroxide-induced toxicity
    Aiman Abdulghader Shalgum, Manoj Govindarajulu, Mohammed Majrashi, Sindhu Ramesh, Willard E. Collier, Gerald D. Griffin, Rajesh Amin, Chastity Bradford, Timothy Moore, Muralikrishnan Dhanasekaran · 2018 · Journal of Herbal Medicine
72. Subregion-specific proteomic signature in the hippocampus for recognition processes in adult mice
    von Ziegler, Lukas M., Selevsek, Nathalie, Tweedie-Cullen, Ry Y., Kremer, Eloïse, Mansuy, Isabelle M. · 2018 · Cell Reports
73. Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson’s Disease
    Rijan Bajracharya, Neil A. Youngson, John William O. Ballard · 2019 · International Journal of Molecular Sciences
74. A New Threat to Dopamine Neurons: The Downside of Artificial Light
    Irene Fasciani, Francesco Petragnano, Gabriella Aloisi, Francesco Marampon, Mario Rossi, Maria Francesca Coppolino, Rodolfo Rossi, Biancamaria Longoni, Marco Scarselli, Roberto Maggio · 2020 · Neuroscience
75. Next-generation sequencing of the whole mitochondrial genome identifies functionally deleterious mutations in patients with multiple sclerosis
    Ghada Al‐Kafaji, Halla Falih Bakheit, Faisal Alali, Mina Fattah, Saad Alhajeri, Maram A. Alharbi, Abdulqader Daif, Manahel Mahmood Alsabbagh, Materah Salem Alwehaidah, Moiz Bakhiet · 2022 · PLoS ONE
76. Competing endogenous RNA (ceRNA) networks in Parkinson's disease: A systematic review
    Mohammad Reza Asadi, Samin Abed, Ghazal Kouchakali, Fateme Fattahi, Hani Sabaie, Marziyeh Sadat Moslehian, Mirmohsen Sharifi‐Bonab, Bashdar Mahmud Hussen, Mohammad Naser Taheri, Soudeh Ghafouri‐Fard et al. · 2023 · Frontiers in Cellular Neuroscience
77. Mitochondrial translation initiation factor 3 polymorphism and Parkinson's disease
    Bahareh Behrouz, Carles Vilariño‐Güell, Michael G. Heckman, Alexandra I. Soto‐Ortolaza, Jan Olav Aasly, Sigrid Botne Sando, Timothy Lynch, David Craig, Ryan J. Uitti, Zbigniew K. Wszołek et al. · 2010 · Neuroscience Letters
78. Why to compare absolute numbers of mitochondria
    Sabine Schmitt, Sabine Schulz, Eva-Maria Schropp, Carola Eberhagen, Alisha Simmons, Wolfgang Beisker, Michaela Aichler, Hans Zischka · 2014 · Mitochondrion
79. TRPC Channels and Parkinson’s Disease
    Pramod Sukumaran, Yuyang Sun, Anne Schaar, Senthil Selvaraj, Brij Bhan Singh · 2017 · Advances in experimental medicine and biology
80. RBX1-mediated ubiquitination of SESN2 promotes cell death upon prolonged mitochondrial damage in SH-SY5Y neuroblastoma cells
    Ashish A. Kumar, Chandrima Shaha · 2018 · Molecular and Cellular Biochemistry
81. Selecting variants of unknown significance through network-based gene-association significantly improves risk prediction for disease-control cohorts
    Anastasis Oulas, George Minadakis, Margarita Zachariou, George M. Spyrou · 2019 · Scientific Reports
82. β-Ecdysterone Protects SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Apoptosis via Mitochondria-Dependent Mechanism: Involvement of p38MAPK–p53 Signaling Pathway
    Pan, Zhi, Niu, Yingcai, Liang, Yini, Zhang, Xiaojie, Dong, Miaoxian · 2016 · Neurotoxicity Research
83. Connecting the dots between mitochondrial dysfunction and Parkinson’s disorder: focus mitochondria-targeting therapeutic paradigm in mitigating the disease severity
    Ishnoor Kaur, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Lotfi Aleya, SIMONA GABRIELA BUNGAU · 2021 · Environmental Science and Pollution Research
84. Proteomics as a new paradigm to tackle Parkinson’s disease research challenges
    Virginie Licker, Pierre R. Burkhard · 2014 · Translational Proteomics
85. C. elegans as a Genetic Model System to Identify Parkinson's Disease- Associated Therapeutic Targets
    Julia Vistbakka, Natalia VanDuyn, Garry Wong, Richard Nass · 2013 · CNS & Neurological Disorders - Drug Targets
86. Novel Redox-Dependent Esterase Activity (EC 3.1.1.2) for DJ-1: Implications for Parkinson’s Disease
    Emmanuel Vazquez‐Mayorga, Ángel G. Díaz‐Sánchez, Ruben Karim Dagda, Carlos Domínguez-Solís, Raul Y. Dagda, Cynthia K Coronado-Ramirez, Alejandro Martı́nez-Martı́nez · 2016 · International Journal of Molecular Sciences
87. Low-Intensity Ultrasound Decreases α-Synuclein Aggregation via Attenuation of Mitochondrial Reactive Oxygen Species in MPP(+)-Treated PC12 Cells
    Mrigendra Bir Karmacharya, Binika Hada, So Ra Park, Byung Hyune Choi · 2016 · Molecular Neurobiology
88. Pinocembrin Attenuates Mitochondrial Dysfunction in Human Neuroblastoma SH-SY5Y Cells Exposed to Methylglyoxal: Role for the Erk1/2–Nrf2 Signaling Pathway
    Marcos Roberto de Oliveira, Alessandra Peres, Gustavo C. Ferreira · 2016 · Neurochemical Research
89. Use of CRISPR/Cas9 to model brain diseases
    Sen Yan, Zhuchi Tu, Shihua Li, Xiao‐Jiang Li · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
90. Isolation of Mitochondria from Cultured Cells and Liver Tissue Biopsies for Molecular and Biochemical Analyses
    Sabine Schmitt, Carola Eberhagen, Susanne Weber, Michaela Aichler, Hans Zischka · 2015 · Methods in molecular biology
91. Cell Phone Radiation Exposure Limits and Engineering Solutions
    Paul Héroux, Igor Y. Belyaev, Kent A. Chamberlin, Süleyman Daşdağ, Álvaro Augusto Almeida de Salles, Claudio Enrique Fernández Rodríguez, Lennart Hardell, Elizabeth Kelley, Kavindra Kumar Kesari, Erica Mallery-Blythe et al. · 2023 · International Journal of Environmental Research and Public Health
92. Effect of Apigenin on Neurodegenerative Diseases
    Kajal Gaur, Yasir Hasan Siddique · 2023 · CNS & Neurological Disorders - Drug Targets
93. OXPHOS toxicogenomics and Parkinson's disease
    Ester López‐Gallardo, Ruth Iceta, Eldris Iglesias, Julio Montoya, Eduardo Ruiz‐Pesini · 2011 · Mutation Research/Reviews in Mutation Research
94. Uptake of the proteins HTRA1 and HTRA2 by cells mediated by calcium phosphate nanoparticles
    Olga Rotan, Katharina N. Severin, Simon Poepsel, Alexander Peetsch, Melisa Merdanovic, Michael Ehrmann, Matthias Epple · 2017 · Beilstein Journal of Nanotechnology
95. Mitochondrial Dynamics Impairment in Dexamethasone-Treated Neuronal Cells
    Wilasinee Suwanjang, Kay L. H. Wu, Supaluk Prachayasittikul, Banthit Chetsawang, Komgrid Charngkaew · 2019 · Neurochemical Research
96. Lipids Nutrients in Parkinson and Alzheimer’s Diseases: Cell Death and Cytoprotection
    Thomas Nury, Gérard Lizard, Anne Véjux · 2020 · International Journal of Molecular Sciences
97. Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy
    An Cheng, Wenbin Jia, K. Kawahata, Kohji Fukunaga · 2021 · Biomedicines
98. Deletion of a Novel F-Box Protein, MUS-10, in Neurospora crassa Leads to Altered Mitochondrial Morphology, Instability of mtDNA and Senescence
    Akihiro Kato, Kiminori Kurashima, Michael S Chae, Satoshi Sawada, Shin Hatakeyama, Shuuitsu Tanaka, Hirokazu Inoue · 2010 · Genetics
99. Understanding the molecular basis of Parkinson’s disease, identification of biomarkers and routes to therapy
    Philip Alan Robinson · 2010 · Expert Review of Proteomics
100. Miro, a Rho GTPase genetically interacts with Alzheimer's disease-associated genes (Tau, Aβ42andAppl) inDrosophila melanogaster
     Komal Panchal, Anand Krishna Tiwari · 2020 · Biology Open